Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fritz Firlinger

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Intensive Care Medicine|June 17, 2015
Understanding the differences among inotropesKurt Lenz, Fritz Firlinger, Robert Buder
Hepatology (Baltimore, Md.)|July 31, 2007
Sepsis-induced cholestasisKurt Lenz, Christine Kapral, Fritz Firlinger, et al.
Wiener Klinische Wochenschrift|November 21, 2014
Effect of proton pump inhibitors on gastric pH in patients exposed to severe stressKurt Lenz, Robert Buder, Fritz Firlinger, et al.
Clinical Chemistry|January 31, 2004
Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failureAlfons Gegenhuber, Thomas Mueller, Fritz Firlinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 2011
Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) studyBenjamin Dieplinger, Margot Egger, Wolfgang Koehler, et al.
Journal of Critical Care|June 12, 2016
Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patientsBenjamin Dieplinger, Margot Egger, Isabella Leitner, et al.
Wiener Klinische Wochenschrift|December 25, 2007
[Steatohepatitis and cirrhosis: first manifestation 23 years after jejunoileal bypass surgery]Peter Piringer, Robert Buder, Fritz Firlinger, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Intensive Care Medicine|June 17, 2015
Understanding the differences among inotropesKurt Lenz, Fritz Firlinger, Robert Buder
Hepatology (Baltimore, Md.)|July 31, 2007
Sepsis-induced cholestasisKurt Lenz, Christine Kapral, Fritz Firlinger, et al.
Wiener Klinische Wochenschrift|November 21, 2014
Effect of proton pump inhibitors on gastric pH in patients exposed to severe stressKurt Lenz, Robert Buder, Fritz Firlinger, et al.
Clinical Chemistry|January 31, 2004
Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failureAlfons Gegenhuber, Thomas Mueller, Fritz Firlinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 2011
Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) studyBenjamin Dieplinger, Margot Egger, Wolfgang Koehler, et al.
Journal of Critical Care|June 12, 2016
Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patientsBenjamin Dieplinger, Margot Egger, Isabella Leitner, et al.
Wiener Klinische Wochenschrift|December 25, 2007
[Steatohepatitis and cirrhosis: first manifestation 23 years after jejunoileal bypass surgery]Peter Piringer, Robert Buder, Fritz Firlinger, et al.
Pageof 1